AVNT AVIENT CORP

FY2025 10-K
Filed: Feb 17, 2026
Health Care
Plastic Materials, Synth Resins & Nonvulcan ElastomersSEC EDGAR

AVIENT CORP (AVNT) filed its fiscal year 2025 10-K annual report with the SEC on Feb 17, 2026. This page provides AI-powered analysis of the filing, including business overview, management discussion, risk factors, and key financial metrics from XBRL data.

AI Filing Analysis
FY2025 10-K

Business Overview

  • Core business model: Innovator and manufacturer of specialty engineered materials, additives, colorants, and composites serving diverse end markets globally
  • No new product segments introduced; continued emphasis on sustainability and innovation with product breadth across polymers and composites
+3 more insights

Management Discussion & Analysis

  • Revenue $3,260M, up 0.6% YoY ($19.8M increase); excluding FX, sales down 0.3%; Specialty Engineered Materials up 2.9%, Color, Additives and Inks down 0.6%
  • Operating income $203.5M, down 38.2% YoY; operating margin 6.2% vs 10.2% in 2024; gross margin 31.2% vs 32.6% in 2024
+3 more insights

Risk Factors

  • Regulatory risk: Potential penalties from violations of FCPA, UK Bribery Act, export control and sanction laws affecting international operations
  • Geopolitical risk: 61% sales outside U.S. exposed to U.S. trade policy changes, tariffs, and retaliatory actions by Canada, Mexico, China, EU
+3 more insights

Financial Summary
XBRL

Revenue

$3.3B

Net Income

$82M

Gross Margin

31.2%

Operating Margin

6.2%

Net Margin

2.5%

ROE

3.4%

Total Assets

$6.0B

EPS (Diluted)

$0.89

Operating Cash Flow

$302M

Source: XBRL data from AVIENT CORP FY2025 10-K filing on SEC EDGAR. All figures in USD.

Get deeper insights on AVIENT CORP

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.

Try Pro free for 1 month!

Enter SX-8KKYTN at checkout

Limited spots available